Current perspectives and trends of the research on hypertensive nephropathy: a bibliometric analysis from 2000 to 2023

Ren Fail. 2024 Dec;46(1):2310122. doi: 10.1080/0886022X.2024.2310122. Epub 2024 Feb 12.

Abstract

Hypertensive nephropathy continues to be a major cause of end-stage renal disease and poses a significant global health burden. Despite the staggering development of research in hypertensive nephropathy, scientists and clinicians can only seek out useful information through articles and reviews, it remains a hurdle for them to quickly track the trend in this field. This study uses the bibliometric method to identify the evolutionary development and recent hotspots of hypertensive nephropathy. The Web of Science Core Collection database was used to extract publications on hypertensive nephropathy from January 2000 to November 2023. CiteSpace was used to capture the patterns and trends from multi-perspectives, including countries/regions, institutions, keywords, and references. In total, 557 publications on hypertensive nephropathy were eligible for inclusion. China (n = 208, 37.34%) was the most influential contributor among all the countries. Veterans Health Administration (n = 19, 3.41%) was found to be the most productive institution. Keyword bursting till now are renal fibrosis, outcomes, and mechanisms which are predicted to be the potential frontiers and hotspots in the future. The top seven references were listed, and their burst strength was shown. A comprehensive overview of the current status and research frontiers of hypertensive nephropathy has been provided through the bibliometric perspective. Recent advancements and challenges in hypertensive nephropathy have been discussed. These findings can offer informative instructions for researchers and scholars.

Keywords: Hypertensive nephropathy; bibliometric analysis; chronic kidney disease; renal fibrosis; research progress.

Publication types

  • Review

MeSH terms

  • Bibliometrics
  • China / epidemiology
  • Humans
  • Hypertension, Renal*
  • Nephritis*

Supplementary concepts

  • Hypertensive Nephropathy

Grants and funding

The work was supported by the National High Level Hospital Clinical Research Funding (Interdisciplinary Research Project of Peking University First Hospital) [2023IR12]; the National Natural Science Foundation of China [82170711, 82070733, 82000680]; Beijing Nova Program [20220484147]; the ‘PRO•Run’ Fund of the Nephrology Group of CEBM [KYS2021-03-02-16]; Beijing Natural Science Foundation[7242144, 7224346]; and the Fundamental Research Funds for the Central Universities.